Repurposing Levofloxacin as a Chemosensitizer to Enhance Doxorubicin Efficacy in TNBC: Role of Mitochondrial Biogenesis and p53-Bypass Mechanisms | Synapse
May 11, 2026
Repurposing Levofloxacin as a Chemosensitizer to Enhance Doxorubicin Efficacy in TNBC: Role of Mitochondrial Biogenesis and p53-Bypass Mechanisms
Key Points
Key points are not available for this paper at this time.